Hepatitis C Virus
Study looks at hepatitis antibody in bone marrow transplant patients
Published in Blood Weekly, August 19th, 2004
Researchers writing in the journal Bone Marrow Transplantation report that "hepatitis C virus (HCV) infection may change the outcome of patients undergoing stem cell transplantation. This study aimed at determining the prevalence of the HCV antibody in patients who were alive 10 or more years after BMT, defining the annual progression rate of hepatic fibrosis in those patients, and identifying cases of cirrhosis among those who were positive for HCV antibody."
"Between 1979 and 1990, 259 patients had a bone marrow transplant, and 91 were alive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-08-19)
More Articles from Blood Weekly
- Blood Donation
American Red Cross renews blood donation technology agreement with Haemonetics - Blood Products
Naturlose to be studied to extend blood shelf life - Blood Substitute
First interim analysis of polyheme ambulance study data announced - Hepatitis Epidemiology
HBV and HCV seromarker prevalence among blood donors in Saudi Arabia reported - Stem Cell Research
bHLH gene over-expression facilitates neural formation of embryonic stem cells - Allergy & Immunology
IL-1 receptor antagonist attenuates airway hyperresponsiveness to ozone - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
